Showing results (1091-1100 of 1,133) with videos related to

Sort By:
Pageof 114
Pigment Cell & Melanoma Research|May 26, 2017
The first transepidermal transplantation of non-cultured epidermal suspension using a dermarolling system in vitiligo: A sequential histological and clinical studyLaila Benzekri, Yvon Gauthier
Pigment Cell & Melanoma Research|June 20, 2017
Arginase-2, a miR-1299 target, enhances pigmentation in melasma by reducing melanosome degradation via senescence-induced autophagy inhibitionNan-Hyung Kim, Soo-Hyun Choi, Nayoung Yi, et al.
Pigment Cell & Melanoma Research|May 20, 2018
BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumorsDeon B Doxie, Allison R Greenplate, Jocelyn S Gandelman, et al.
Pigment Cell & Melanoma Research|September 6, 2016
NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patientsAihua Wei, Yefeng Yuan, Dayong Bai, et al.
Pigment Cell & Melanoma Research|May 16, 2017
Recognizing Latinos' range of skin pigment and phototypes to enhance skin cancer preventionJune K Robinson, Frank J Penedo, Jennifer L Hay, et al.
Pigment Cell & Melanoma Research|June 27, 2017
Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanomaHannah E Seberg, Eric Van Otterloo, Robert A Cornell
Pigment Cell & Melanoma Research|June 11, 2014
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysisSimon J Furney, Samra Turajlic, Gordon Stamp, et al.
Pigment Cell & Melanoma Research|January 21, 2014
Type I interferon signature in the initiation of the immune response in vitiligoAntoine Bertolotti, Katia Boniface, Beatrice Vergier, et al.
Pigment Cell & Melanoma Research|February 4, 2015
Exploration of peptides bound to MHC class I molecules in melanomaAntonia L Pritchard, Marcus L Hastie, Michelle Neller, et al.
Pigment Cell & Melanoma Research|October 2, 2012
Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screeningYong Qin, Wuguo Deng, Suhendan Ekmekcioglu, et al.
Pageof 114